Sandra Lippold

High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G

Susanne Preithner, Stefanie Elm, Sandra Lippold et al. · Molecular Immunology · 2005 · 131 citations · Full text

T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct

Bernd Schlereth, Cornelia Quadt, Torsten Dreier et al. · Cancer Immunology Immunotherapy · 2005 · 103 citations · Full text

Autoimmune Disease, Lymphocyte Development, Adaptive Immune System +10

<i>In vitro</i> and <i>in vivo</i> activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment

Stefanie Naundorf, Susanne Preithner, Petra Mayer et al. · International Journal of Cancer · 2002 · 100 citations · Full text

Therapeutic Window of MuS110, a Single-Chain Antibody Construct Bispecific for Murine EpCAM and Murine CD3

Maria Amann, Klaus Brischwein, Petra Lutterbuese et al. · Cancer Research · 2008 · 89 citations

Immunology, Immunodominance, Immunologic Mechanism +17

Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3

Bernd Schlereth, Petra Kleindienst, Iduna Fichtner et al. · Cancer Immunology Immunotherapy · 2005 · 54 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Immunology +11